Visium Technologies signs non-binding term sheet to assign device rights into Indonesian PMA company

VISIUM TECHNOLOGIES, INC.

On Sept 21, 2026, executed non-binding term sheet to assign device rights into new Indonesian PMA company PTVCI; Delaware sub to hold 99% equity.
Consideration expected as Series F non-voting convertible preferred stock in private placement under 4(a)(2)/506(b); no cash unless board authorizes.
Closing subject to final device specs, third-party consents, export-control classification, Indonesian approvals, and Florida law review; no assurance of definitive deal.
Conflict-of-interest: CEO Paul R. Taylor and entity associated with Dr. Niclas Adler have relationships with counterparties; Section 607.0832 review pending.

item 7.01 item 8.01 item 1.01 item 2.01 item 3.02 item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.